If approved, Pfizer’s sasanlimab will distinguish itself from Merck’s blockbuster Keytruda as the first PD-1 inhibitor ...
Based on the OPEN alliance 10BASE-T1S PHY, E2B bus aims at removing the need for MCUs centralizing software to HPC or central ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback